Soligenix, Inc. (NASDAQ:SNGX – Get Free Report) was the target of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 54,100 shares, a growth of 70.7% from the October 31st total of 31,700 shares. Currently, 0.5% of the company’s shares are short sold. Based […]
PCORI funds 4 new large studies focused on maternal health fiercehealthcare.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercehealthcare.com Daily Mail and Mail on Sunday newspapers.
Soligenix, Inc Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing.
PRINCETON, N.J., Nov. 17, 2023 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an.